美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Generate Biomedicines

12.61

+0.11000.88%

盘后：12.610.00000.00%17:23 EDT

成交量：29.14万

成交额：367.22万

市值：16.07亿

市盈率：-6.44

高：12.88

开：12.60

低：12.35

收：12.50

52周最高：15.32

52周最低：11.00

股本：1.27亿

流通股本：2,500.00万

量比：0.85

换手率：1.17%

股息：- -

股息率：- -

每股收益(TTM):-1.9580

每股收益(LYR):-4.9816

净资产收益率：-81.72%

总资产收益率：-34.63%

市净率：-2.61

市盈率(LYR):-2.53

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Generate Biomedicines

交易所：

NASDAQ

成立时间：

2018

员工人数：

312

公司地址：

101 South Street,Suite 900,Somerville,Massachusetts,United States

官网：

http://www.generatebiomedicines.com

邮编：

02143

电话：

传真：

- -

简介：

Generate Biomedicines, Inc.于2018年8月根据特拉华州法律成立。作为一家临床阶段的生成生物学公司，该公司首创了名为Generate Platform的人工智能驱动的生物技术平台，该平台将计算模型与可扩展的生物硬件相结合，以设计和开发新型治疗性蛋白质。其最先进的候选药物GB-0895是一种计算工程抗TSLP单克隆抗体，目前正处于严重哮喘的关键3期试验中。该平台的能力已通过在2026年将另外两个肿瘤候选药物推向1期试验而得到进一步证明。

董事

名称

职位

Michael Nally

Chief Executive Officer and Director

Noubar B. Afeyan

Chairperson of the Board

Frances Arnold

Director

Jane Mendillo

Director

Marsha H. Fanucci

Director

Nancy A. Simonian

Director

Paul Parker

Director

Rupert Vessey

Director

Stéphane Bancel

Director

股东

名称

职位

Michael Nally

Chief Executive Officer and Director

Jason Silvers

Chief Financial Officer and President

Aarif Khakoo

Chief Scientific Officer

Beth Grous

Chief People Officer

Gevorg Grigoryan

Chief Technology Officer and Co-Founder

Laurie Lee

Chief Medical Officer

Sean Martin

Chief Legal Officer and General Counsel

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/GENB/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GENB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GENB\",,,,,undefined,":{"symbol":"GENB","market":"US","secType":"STK","nameCN":"Generate Biomedicines","latestPrice":12.61,"timestamp":1776369600000,"preClose":12.5,"halted":0,"volume":291397,"hourTrading":{"tag":"盘后","latestPrice":12.61,"preClose":12.61,"latestTime":"17:23 EDT","volume":610,"amount":7691.9,"timestamp":1776374616462,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.008799999999999954,"floatShares":25000000,"shares":127450200,"eps":-1.958,"marketStatus":"未开盘","change":0.11,"latestTime":"04-16 16:00:00 EDT","open":12.6,"high":12.88,"low":12.35,"amount":3672204.808996,"amplitude":0.0424,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.958,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1776412800000},"marketStatusCode":0,"adr":0,"listingDate":1772168400000,"exchange":"NASDAQ","adjPreClose":12.5,"preHourTrading":{"tag":"盘前","latestPrice":12.51,"preClose":12.5,"latestTime":"09:28 EDT","volume":190,"amount":2424.00993,"timestamp":1776346119624,"change":0.01,"changeRate":0.0008,"amplitude":0.036},"postHourTrading":{"tag":"盘后","latestPrice":12.61,"preClose":12.61,"latestTime":"17:23 EDT","volume":610,"amount":7691.9,"timestamp":1776374616462,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.853717},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GENB\",,,,,undefined,":{"symbol":"GENB","floatShares":25000000,"roa":"-34.63%","roe":"-81.72%","lyrEps":-4.981642,"volumeRatio":0.853717,"shares":127450200,"dividePrice":0,"high":12.88,"amplitude":0.0424,"preClose":12.5,"low":12.35,"week52Low":11,"pbRate":"-2.61","psRate":"50.39","week52High":15.32,"institutionHeld":0,"latestPrice":12.61,"eps":-1.958,"divideRate":0,"volume":291397,"delay":0,"ttmEps":-1.958,"open":12.6,"prevYearClose":16,"prevWeekClose":11.41,"prevMonthClose":12.5,"prevQuarterClose":12.5,"fiveDayClose":11.53,"twentyDayClose":11.81,"sixtyDayClose":16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GENB\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GENB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GENB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1776139200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GENB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GENB","date":"2026-04-15","current":-6.440245,"percent":0.15625,"low":-10.037721,"twenty":-8.048998,"median":-7.660036,"eighty":-7.414112,"high":-7.032678,"avg":-7.763645,"sd":0.548051,"marketCap":1642833090},"quantilePoints":[{"date":"2026-02-27","current":-10.037721,"twenty":-10.037721,"median":-10.037721,"eighty":-10.037721,"marketCap":2039203216},{"date":"2026-03-06","current":-7.810602,"twenty":-7.936073,"median":-7.722772,"eighty":-7.484376,"marketCap":1586755002},{"date":"2026-03-13","current":-8.331309,"twenty":-7.979988,"median":-7.660036,"eighty":-7.484376,"marketCap":1692538669},{"date":"2026-03-20","current":-7.710225,"twenty":-7.979988,"median":-7.68513,"eighty":-7.484376,"marketCap":1566362970},{"date":"2026-03-27","current":-8.061545,"twenty":-7.979988,"median":-7.697677,"eighty":-7.484376,"marketCap":1637735082},{"date":"2026-04-02","current":-8.350129,"twenty":-7.996299,"median":-7.697677,"eighty":-7.419131,"marketCap":1696362175},{"date":"2026-04-10","current":-7.233433,"twenty":-7.996299,"median":-7.647489,"eighty":-7.419131,"marketCap":1469500817},{"date":"2026-04-15","current":-8.086639,"twenty":-8.048998,"median":-7.660036,"eighty":-7.414112,"marketCap":1642833090}],"updateTime":1776401576058},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":659065371,"yearFounded":2018,"employeeNum":312,"address":"101 South Street,Suite 900,Somerville,Massachusetts,United States","zipCode":"02143","officePhone":"(888) 469-0055","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.generatebiomedicines.com","stockEarnings":[{"period":"1week","weight":0.0937},{"period":"1month","weight":0.0202},{"period":"3month","weight":-0.2119},{"period":"ytd","weight":-0.2119}],"compareEarnings":[{"period":"1week","weight":0.032},{"period":"1month","weight":0.046},{"period":"3month","weight":0.0145},{"period":"6month","weight":0.0561},{"period":"1year","weight":0.3348},{"period":"ytd","weight":0.0289}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Generate Biomedicines, Inc.于2018年8月根据特拉华州法律成立。作为一家临床阶段的生成生物学公司，该公司首创了名为Generate Platform的人工智能驱动的生物技术平台，该平台将计算模型与可扩展的生物硬件相结合，以设计和开发新型治疗性蛋白质。其最先进的候选药物GB-0895是一种计算工程抗TSLP单克隆抗体，目前正处于严重哮喘的关键3期试验中。该平台的能力已通过在2026年将另外两个肿瘤候选药物推向1期试验而得到进一步证明。","exchange":"NASDAQ","name":"Generate Biomedicines","nameEN":"Generate Biomedicines"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"GENB\",market:\"US\",,,undefined,":{"directors":[{"name":"Michael Nally","position":"Chief Executive Officer and Director"},{"name":"Noubar B. Afeyan","position":"Chairperson of the Board"},{"name":"Frances Arnold","position":"Director"},{"name":"Jane Mendillo","position":"Director"},{"name":"Marsha H. Fanucci","position":"Director"},{"name":"Nancy A. Simonian","position":"Director"},{"name":"Paul Parker","position":"Director"},{"name":"Rupert Vessey","position":"Director"},{"name":"Stéphane Bancel","position":"Director"}],"executives":[{"name":"Michael Nally","position":"Chief Executive Officer and Director"},{"name":"Jason Silvers","position":"Chief Financial Officer and President"},{"name":"Aarif Khakoo","position":"Chief Scientific Officer"},{"name":"Beth Grous","position":"Chief People Officer"},{"name":"Gevorg Grigoryan","position":"Chief Technology Officer and Co-Founder"},{"name":"Laurie Lee","position":"Chief Medical Officer"},{"name":"Sean Martin","position":"Chief Legal Officer and General Counsel"}]}}}